Reversed-phase high-performance liquid chromatographic analysis of atenolol enantiomers in plasma after chiral derivatization with (+)-1-(9-fluorenyl)ethyl chloroformate
- 17 July 1991
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 568 (1), 239-245
- https://doi.org/10.1016/0378-4347(91)80359-k
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Pharmacokinetics of Atenolol Enantiomers in Humans and RatsJournal of Pharmaceutical Sciences, 1990
- High-performance liquid chromatographic determination of the enantiomers of β-adrenoceptor blocking agents in biological fluids : II. Studies with atenololJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- Liquid Chromatographic Analysis of Atenolol Enantiomers in Human Plasma and UrineJournal of Pharmaceutical Sciences, 1989
- Separation and quantitation of (R)‐ and (S)‐atenolol in human plasma and urine using an α1‐AGP columnChirality, 1989
- Preparative resolution of the enantiomers of the β-blocking drug atenolol by chiral derivatization and high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1988
- Separation of amino acid enantiomers and chiral amines using precolumn derivatization with (+)-1-(9-fluorenyl)ethyl chloroformate and reversed-phase liquid chromatographyAnalytical Chemistry, 1987